Back
Actinium Pharmaceuticals 10K Form
Sell
50
ATNM
Actinium Pharmaceuticals
Last Price:
5.67
Seasonality Move:
3.07%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ATNM News And Ratings
See the #1 stock for the next 7 days that we like better than ATNM
ATNM Financial Statistics
Sales & Book Value
| Annual Sales: | $1.14M |
|---|---|
| Cash Flow: | $-5.79M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.11 |
| Price / Book: | 1.89 |
Profitability
| EPS (TTM): | -1.14000 |
|---|---|
| Net Income (TTM): | $-24.58M |
| Gross Margin: | $0 |
| Return on Equity: | -32.87% |
| Return on Assets: | -30.81% |
Actinium Pharmaceuticals Earnings Forecast
Key Actinium Pharmaceuticals Financial Ratios
- The Selling, General & Administrative Expenses for ATNM have been equal to 708.77% of Gross Profit Margin.
- The Research & Development expenses have been 1,581.58% of Revenue.
- The Interest Expense is -0.04% of Operating Income.
- Per Share Earnings over the last 16 years have been positive in 9 years.
Actinium Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYAM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Current Symbol: | ATNM |
| CUSIP: | 00507W |
| Website: | actiniumpharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 12.94 |
| Quick Ratio: | 12.58 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ATNM Technical Analysis vs Fundamental Analysis
Sell
50
Actinium Pharmaceuticals (ATNM)
is a Sell
Is Actinium Pharmaceuticals a Buy or a Sell?
-
Actinium Pharmaceuticals stock is rated a Sell
The current Actinium Pharmaceuticals [ATNM] share price is $5.41. The Score for ATNM is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.